ViaDerma, Inc. VDRM
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0005 Day range 0.008
0.0001 52-week range 0.008
- YTD
- -50.00%
- 1 year
- 0.00%
- Open
- 0.008
- Prev close
- 0.0001
- Mkt cap
- 123.37K
- Vol
- 4.10K
- Avg vol
- 124.86K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.0005
- High
- 0.008
3M chart
Signals (29)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 10, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| RSI: Oversold | Aug 3, 2026 | 3 months ago |
News
- ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance
- ViaDerma Announces Shipment of 500,000 Units of its Flagship Product to Nigeria
- ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
- ViaDerma Provides Highlights of Quarterly Financial Report
- ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
- ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
- ViaDerma, Inc. Files Amended Financial Statements
- ViaDerma, Inc. Provides Updates on Current Business Activities
- ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
- ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
Your note
Sign in to keep a note on VDRM — it syncs with the Stock Master app.